39,060 bottles of Clear Eyes itchy-eye drops were pulled because the maker can’t promise they’re sterile

A widely stocked eye drop brand used to relieve itchy, allergy-prone eyes is missing from some store shelves after its manufacturer determined it could not guarantee the product was free of bacteria or fungi. Tens of thousands of bottles have been pulled nationwide, not because contamination was confirmed, but because the company that makes them lost confidence in the sterility of the batch. For a product that gets squeezed directly onto the surface of the eye, that gap between “possibly contaminated” and “definitely sterile” is enough to trigger a formal recall.

What Triggered the Sterility Concern

The recall covers 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief, a 0.5-fluid-ounce lubricant eye drop distributed nationwide by Medtech Products, a subsidiary of Prestige Consumer Healthcare. The affected bottles carry an expiration date of September 30, 2027, and a specific lot code, meaning most bottles of the same product already sitting in medicine cabinets are not automatically part of the recall unless they match that lot. Regulators describe the underlying issue as a “lack of assurance of sterility” during manufacturing, a distinct and narrower finding than confirmed contamination, but one that still means the company cannot rule out the presence of bacteria or fungi in any given bottle from that production run. Sterility problems in liquid medications typically trace back to the manufacturing environment itself, such as a gap in an air-filtration system, a contaminated piece of equipment, or a lapse in the sealed conditions required to fill bottles without introducing outside microbes, rather than to anything a consumer did after purchase. Manufacturers are required to test samples from each production run before releasing it for sale, and a “lack of assurance” finding generally means that testing turned up results ambiguous or inconsistent enough that the company could not certify the entire batch as clean, even without a confirmed positive result for contamination.

Why Regulators Rated It a Class II Recall

The recall was classified by federal drug regulators as a Class II action, a category reserved for products whose use could cause temporary or medically reversible health problems, or that carry only a remote chance of more serious harm. That is a step below the most severe recall category, which is reserved for situations where a product could cause serious injury or death, and it reflects the fact that no injuries had been linked to the eye drops at the time the recall was announced. Even so, eye drops occupy an unusually sensitive category among over-the-counter products, since anything applied directly to the eye bypasses much of the body’s normal defense against introduced microbes, and past contamination incidents involving other eye drop brands have led to serious eye infections in rare cases. Symptoms that would warrant medical attention after using a contaminated eye product generally include unusual redness, discharge, pain, blurred vision or increased light sensitivity that develops after applying the drops, since those signs can indicate a developing infection rather than the itching or irritation the product was meant to relieve in the first place.

How the Timeline Unfolded

The manufacturer initiated the recall in late July, and it was formally logged with a Class II designation in mid-August, with wider news coverage following in the weeks after. That sequence is typical for pharmaceutical and consumer-health recalls, where a company’s internal decision to pull a product from distribution often precedes the regulatory classification and public notice by several weeks. For consumers, the practical takeaway does not change with that lag: bottles matching the recalled lot remain unsafe to use regardless of when the recall was first announced, and the recall stays in effect until affected inventory has been removed from stores and returned. Retailers that carried the affected lot are typically notified directly by the manufacturer and instructed to pull matching bottles from shelves, though a recall notice does not guarantee that every unit has already been removed by the time a consumer checks their own medicine cabinet, which is part of why regulators continue publicizing recalls for weeks after the initial notice goes out.

What to Check on a Bottle at Home

Anyone with a bottle of Clear Eyes Maximum Itchy Eye Relief in a medicine cabinet or travel bag can check it against two specific details: the lot code and the printed expiration date. Only bottles bearing the affected lot code and matching expiration date are covered by the recall, so a differently dated bottle of the same product is not necessarily affected. Consumers who confirm a match are generally advised to stop using the product immediately, since continued use of a bottle that cannot be guaranteed sterile carries a small but real risk of eye irritation or infection, particularly for anyone using the drops on already irritated or itchy eyes, which is the exact population the product is marketed to in the first place. Consumers who are unsure whether they still have the original packaging can typically find the lot code printed near the bottom of the bottle or on the box it came in, and pharmacists are generally able to help confirm whether a specific code matches a recall if the printed text is too small or worn to read clearly.

The Broader Pattern in Eye Drop Recalls

This recall follows a string of eye drop safety actions across the industry in recent years, as regulators have tightened scrutiny of over-the-counter ophthalmic products after contamination problems at several manufacturers led to serious infections and, in some earlier cases, vision loss. Eye drops are manufactured under sterility requirements that are stricter than those for most oral over-the-counter medicines precisely because the eye has fewer natural barriers against introduced pathogens than the digestive tract does. Consumers who want to avoid affected products going forward can watch for recall notices from the specific brand and lot rather than assuming an entire product line is being pulled, since manufacturers typically recall discrete production batches rather than a brand’s full inventory. That distinction is part of why a recall of tens of thousands of bottles from a single lot code does not necessarily reflect a problem with the underlying formula or with every bottle of that product sold nationwide, even though the recall notice itself can look alarming at first glance to someone who owns the same brand but a different lot.

This article was produced with AI assistance and edited by Morning Overview staff.

More from Morning Overview